Photo: Courtesy of Teva
Pharmaceutical company Teva has bought Mexico-based Representaciones e Investigaciones Médicas (Rimsa), in a deal totalling $2.3 billion (£1.6 billion).
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Teva, Rimsa, mergers & acquisitions, pharmaceutical, IP, patent, Erez Vigodman, patent, Representaciones e Investigaciones Médicas,
